This study investigated ocular (eye) conditions (OCs) in patients with rheumatoid arthritis (RA). They found that OCs affect approximately 20% of patients with RA.

This study wanted to find out if taking pictures of lymph nodes using medical imaging techniques helped in finding out if treatment for lymph node swelling was working. The study found that using lymphoscintigraphy helped in evaluating the treatment of lymph node swelling. 

This study investigated how rheumatoid arthritis (RA)and its treatment may affect bone mineral density (BMD). They found that RA was associated with a reduced BMD and an increased risk of falls and fractures. 

This review aimed to summarize available data about the effectiveness of mindfulness-based interventions for cancer-related symptoms in cancer patients and survivors.  

This review concluded that mindfulness-based interventions can have a beneficial effect as an adjuvant therapy in these patients.  

This study investigated patient-reported outcomes (PROs) in patients taking upadacitinib (Rinvoq) to treat rheumatoid arthritis (RA). They found that this treatment improved the quality of life (QoL) in these patients.

This study wanted to find out how well chemotherapy for invasive breast cancer works, especially in those over 70 years old. The study found that most patients benefit from chemotherapy, however, those aged over 70 benefited less of this treatment than those aged under 70.

This study investigated the effect of dietary fiber supplementation (DFS) in patients with rheumatoid arthritis (RA). They found that DFS may improve RA symptoms.

This study investigated the safety and effectiveness of different doses of peficitinib (Smyraf; PFC) in treating rheumatoid arthritis (RA). They found that PFC doses of 50 mg or higher were the most effective in these patients.

This study investigated the risk of serious infections with tumor necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis (RA).

They found no difference in serious infection risk with TNFi treatment compared to triple therapy.

This study investigated if there is a higher risk of cardiovascular disease (CVD) in cancer survivors. They found that cancer survivors have a higher risk of CVD.